Lesley Stanley: Review of data on the food additive aspartame. Supporting Publication 2013:EN-399 der EFSA, 2013. doi:10.2903/sp.efsa.2013.EN-399
Alternativen zu Zucker: Wie viel Süßungsmittel steckt in Erfrischungsgetränken?: Stellungnahme Nr. 006/2023 des BfR vom 07. Februar 2023. In: BfR-Stellungnahmen. Band2023, Nr.006, 2023, doi:10.17590/20230207-072340.
Andrea Conz et al.: Effect of Non-Nutritive Sweeteners on the Gut Microbiota. In: Nutrients. Band15, Nr.8, 13. April 2023, S.1869, doi:10.3390/nu15081869, PMID 37111090 (englisch).
Sarah Gul et al.: Inhibition of the gut enzyme intestinal alkaline phosphatase may explain how aspartame promotes glucose intolerance and obesity in mice. In: Applied Physiology, Nutrition, and Metabolism. Band 42, Nr. 1, Januar 2017, doi:10.1139/apnm-2016-0346, PMC 5686455 (freier Volltext), S. 77–83.
B A Magnuson u. a.: Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. In: Critical Reviews in Toxicology. Band37, Nr.8, 2007, S.629–727, doi:10.1080/10408440701516184 (englisch).
Karol Rycerz, Jadwiga Elżbieta Jaworska-Adamu: Review paper: Effects of aspartame metabolites on astrocytes and neurons. In: Folia Neuropathologica. Band51, Nr.1, 28. März 2013, S.10–17, doi:10.5114/fn.2013.34191 (englisch).
Glenda N. Lindseth, Sonya E. Coolahan, Thomas V. Petros, Paul D. Lindseth: Neurobehavioral Effects of Aspartame Consumption. In: Research in Nursing & Health. Band37, Nr.3, 1. Juni 2014, S.185–193, doi:10.1002/nur.21595 (englisch).
Christina Sun-Edelstein, Alexander Mauskop: Foods and supplements in the management of migraine headaches. In: The Clinical Journal of Pain. Band25, Nr.5, Juni 2009, S.446–452, doi:10.1097/AJP.0b013e31819a6f65, PMID 19454881 (englisch).
B. A. Magnuson et al.: Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. In: Critical Reviews in Toxicology. Band37, Nr.8, 2007, S.629–727, doi:10.1080/10408440701516184, PMID 17828671 (englisch).
Harriett H. Butchko et al.: Aspartame: review of safety. In: Regulatory toxicology and pharmacology: RTP. Band35, 2 Pt 2, April 2002, S.S1–93, doi:10.1006/rtph.2002.1542, PMID 12180494 (englisch).
"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs. In: Pediatrics. Band99, Nr.2, Februar 1997, S.268–278, doi:10.1542/peds.99.2.268, PMID 9024461 (englisch).
European Food Safety Authority (EFSA): Report of the meeting on Aspartame with National Experts. In: EFSA Supporting Publications. Band7, Nr.5, Mai 2010, doi:10.2903/sp.efsa.2010.ZN-002 (englisch).
John W. Olney et al.: Increasing brain tumor rates: is there a link to aspartame? In: Journal of Neuropathology and Experimental Neurology. Band55, Nr.11, November 1996, S.1115–1123, doi:10.1097/00005072-199611000-00002, PMID 8939194 (englisch).
Morando Soffritti et al.: Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. doi:10.1289/ehp.10271.
Updated opinion on a request from the European Commission related to the 2nd ERF carcinogenicity study on aspartame, taking into consideration study data submitted by the Ramazzini Foundation in February 2009. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), 26. Mai 2009, doi:10.2903/j.efsa.2009.1015
Unhee Lim et al.: Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. In: Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. Band15, Nr.9, September 2006, S.1654–1659, doi:10.1158/1055-9965.EPI-06-0203, PMID 16985027 (englisch).
Lois Haighton et al.: Evaluation of aspartame cancer epidemiology studies based on quality appraisal criteria. In: Regulatory toxicology and pharmacology: RTP. Band103, April 2019, S.352–362, doi:10.1016/j.yrtph.2019.01.033, PMID 30716379 (englisch).
W. M. Bernardo et al.: Adverse effects of the consumption of artificial sweeteners - systematic review. In: Revista Da Associacao Medica Brasileira (1992). Band62, Nr.2, April 2016, S.120–122, doi:10.1590/1806-9282.62.02.120, PMID 27167540 (englisch).
Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive. In: EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) (Hrsg.): EFSA Journal. Band11, Nr.12, 10. Dezember 2013, doi:10.2903/j.efsa.2013.3496 (englisch).
Charlotte Debras et al.: Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study. In: PLOS Medicine. Band19, Nr.3, 24. März 2022, S.e1003950, doi:10.1371/journal.pmed.1003950, PMID 35324894, PMC 8946744 (freier Volltext) – (englisch).
Thorhallur I. Halldorsson et al.: Intake of artificially sweetened soft drinks and risk of preterm delivery: a prospective cohort study in 59,334 Danish pregnant women. In: The American Journal of Clinical Nutrition. Band92, Nr.3, September 2010, S.626–633, doi:10.3945/ajcn.2009.28968, PMID 20592133 (englisch).
Morando Soffritti et al.: Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice. In: American Journal of Industrial Medicine. Band53, Nr.12, Dezember 2010, S.1197–1206, doi:10.1002/ajim.20896 (englisch).
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS): Scientific Opinion on the re‐evaluation of aspartame (E 951) as a food additive. In: EFSA Journal. Band11, Nr.12, Dezember 2013, doi:10.2903/j.efsa.2013.3496 (englisch).
Andrea Conz et al.: Effect of Non-Nutritive Sweeteners on the Gut Microbiota. In: Nutrients. Band15, Nr.8, 13. April 2023, S.1869, doi:10.3390/nu15081869, PMID 37111090 (englisch).
Sarah Gul et al.: Inhibition of the gut enzyme intestinal alkaline phosphatase may explain how aspartame promotes glucose intolerance and obesity in mice. In: Applied Physiology, Nutrition, and Metabolism. Band 42, Nr. 1, Januar 2017, doi:10.1139/apnm-2016-0346, PMC 5686455 (freier Volltext), S. 77–83.
R. G. Walton, R. Hudak, R. J. Green-Waite: Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population. In: Biological Psychiatry. Band34, Nr.1-2, 15. Juli 1993, S.13–17, PMID 8373935 (englisch).
Christina Sun-Edelstein, Alexander Mauskop: Foods and supplements in the management of migraine headaches. In: The Clinical Journal of Pain. Band25, Nr.5, Juni 2009, S.446–452, doi:10.1097/AJP.0b013e31819a6f65, PMID 19454881 (englisch).
B. A. Magnuson et al.: Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. In: Critical Reviews in Toxicology. Band37, Nr.8, 2007, S.629–727, doi:10.1080/10408440701516184, PMID 17828671 (englisch).
Harriett H. Butchko et al.: Aspartame: review of safety. In: Regulatory toxicology and pharmacology: RTP. Band35, 2 Pt 2, April 2002, S.S1–93, doi:10.1006/rtph.2002.1542, PMID 12180494 (englisch).
"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs. In: Pediatrics. Band99, Nr.2, Februar 1997, S.268–278, doi:10.1542/peds.99.2.268, PMID 9024461 (englisch).
John W. Olney et al.: Increasing brain tumor rates: is there a link to aspartame? In: Journal of Neuropathology and Experimental Neurology. Band55, Nr.11, November 1996, S.1115–1123, doi:10.1097/00005072-199611000-00002, PMID 8939194 (englisch).
Unhee Lim et al.: Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. In: Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. Band15, Nr.9, September 2006, S.1654–1659, doi:10.1158/1055-9965.EPI-06-0203, PMID 16985027 (englisch).
Lois Haighton et al.: Evaluation of aspartame cancer epidemiology studies based on quality appraisal criteria. In: Regulatory toxicology and pharmacology: RTP. Band103, April 2019, S.352–362, doi:10.1016/j.yrtph.2019.01.033, PMID 30716379 (englisch).
W. M. Bernardo et al.: Adverse effects of the consumption of artificial sweeteners - systematic review. In: Revista Da Associacao Medica Brasileira (1992). Band62, Nr.2, April 2016, S.120–122, doi:10.1590/1806-9282.62.02.120, PMID 27167540 (englisch).
Charlotte Debras et al.: Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study. In: PLOS Medicine. Band19, Nr.3, 24. März 2022, S.e1003950, doi:10.1371/journal.pmed.1003950, PMID 35324894, PMC 8946744 (freier Volltext) – (englisch).
Thorhallur I. Halldorsson et al.: Intake of artificially sweetened soft drinks and risk of preterm delivery: a prospective cohort study in 59,334 Danish pregnant women. In: The American Journal of Clinical Nutrition. Band92, Nr.3, September 2010, S.626–633, doi:10.3945/ajcn.2009.28968, PMID 20592133 (englisch).